Participants were assessed on three separate testing days, during which they were screened for in- and exclusion criteria, underwent a magnetic resonance imaging (MRI) scan (see below), and completed measures of social defeat and an [18F]-FDOPA PET/CT-scan. All participants signed informed consent prior to the start of the study. The study was approved by the medical ethics committee of Leiden University Medical Center (reference NL54244.058.15), and pre-registered within the Netherlands Trial Register (registration number NL6207,

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.